tradingkey.logo

Intelligent Bio Solutions Inc

INBS
View Detailed Chart
6.230USD
-0.090-1.42%
Close 02/06, 16:00ETQuotes delayed by 15 min
5.67MMarket Cap
LossP/E TTM

Intelligent Bio Solutions Inc

6.230
-0.090-1.42%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.42%

5 Days

-28.31%

1 Month

-41.78%

6 Months

+299.36%

Year to Date

-34.63%

1 Year

+219.49%

View Detailed Chart

Key Insights

Intelligent Bio Solutions Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 205 out of 392 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 12.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Intelligent Bio Solutions Inc's Score

Industry at a Glance

Industry Ranking
205 / 392
Overall Ranking
399 / 4521
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Intelligent Bio Solutions Inc Highlights

StrengthsRisks
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 142.87% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.05M.
Fairly Valued
The company’s latest PE is -0.38, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 129.36K shares, decreasing 0.91% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
12.000
Target Price
+455.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Intelligent Bio Solutions Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Intelligent Bio Solutions Inc Info

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Ticker SymbolINBS
CompanyIntelligent Bio Solutions Inc
CEOSimeonidis (Harry)
Websitehttps://ibs.inc/
KeyAI